针对癌症相关的糖抗原的基于抗体的策略取得了进展

Edward P W Meier1, Andreas H Laustsen1

  • 1Department of Biotechnology and Biomedicine, Technical University of Denmark, DK-2800 Kongens Lyngby, Denmark.

Drug discovery today
|October 23, 2025
PubMed
概括

在开发向癌症疗法时,研究人员设计了抗体来识别瘤相关碳水化合物抗原 (TACAs) 和相邻的氨基酸. 这一策略提高了抗体的特异性和有效性,同时最大限度地减少了副作用.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K